Thi Bich Uyen Le

1PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 12, 2020
Ribociclib enhances infigratinib-induced cancer cell differentiation and delays resistance in FGFR-driven hepatocellular carcinoma.

Aldo Prawira, Thi Bich Uyen Le, Thanh Chung Vu

Pageof 1

Frequent Collaborators

1 joint publications

Aldo Prawira

1 joint publications

Thanh Chung Vu

1 joint publications

Hung Huynh